Showing results (161-170 of 824) with videos related to
Sort By:
Pageof 83
British Journal of Haematology|September 16, 2009
In vitro anti-myeloma activity of the Aurora kinase inhibitor VE-465Joseph M Negri, Douglas W McMillin, Jake Delmore, et al.Cancer Research|October 3, 2003
Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of beta1-integrin and phosphatidylinositol 3'-kinase/AKT signalingYu-Tzu Tai, Klaus Podar, Laurence Catley, et al.Blood|May 5, 2005
Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosisKenji Ishitsuka, Teru Hideshima, Makoto Hamasaki, et al.Cell Chemical Biology|October 24, 2017
Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7Ilaria Lamberto, Xiaoxi Liu, Hyuk-Soo Seo, et al.Oncogene|June 9, 2005
Novel inosine monophosphate dehydrogenase inhibitor VX-944 induces apoptosis in multiple myeloma cells primarily via caspase-independent AIF/Endo G pathwayKenji Ishitsuka, Teru Hideshima, Makoto Hamasaki, et al.Blood|April 9, 2004
The bortezomib/proteasome inhibitor PS-341 and triterpenoid CDDO-Im induce synergistic anti-multiple myeloma (MM) activity and overcome bortezomib resistanceDharminder Chauhan, Guilan Li, Klaus Podar, et al.Blood|November 9, 2002
The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applicationsNicholas Mitsiades, Constantine S Mitsiades, Paul G Richardson, et al.Blood|January 24, 2009
The proteasome load versus capacity balance determines apoptotic sensitivity of multiple myeloma cells to proteasome inhibitionGiada Bianchi, Laura Oliva, Paolo Cascio, et al.Chinese Medical Journal|July 12, 2011
Near-fatal infection following an elective ankle-fracture fixation: less risk should not mean less vigilanceGiada Bianchi, Dingxin Qin, Joseph A Dearani, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
Moving toward individualized cancer therapiesGiovanni Tonon, Kenneth C AndersonPageof 83